Company
Inthera Bioscience
SELECTIVE KILLING OF CANCER CELLS THROUGH REPLICATIVE STRESS
- Status
- Operatingas of 2026-09-21
- Business model
- B2B
Claim, correct or request removal
Record updated 28 September 2026
About
Tackling "undruggable" targets with small molecule inhibit
Loading relationship preview